EP1104486A4 - Neues verfahren zur diagnose, zur verlaufsbeobachtung und zum abbilden von lungenkrebs - Google Patents

Neues verfahren zur diagnose, zur verlaufsbeobachtung und zum abbilden von lungenkrebs

Info

Publication number
EP1104486A4
EP1104486A4 EP99935685A EP99935685A EP1104486A4 EP 1104486 A4 EP1104486 A4 EP 1104486A4 EP 99935685 A EP99935685 A EP 99935685A EP 99935685 A EP99935685 A EP 99935685A EP 1104486 A4 EP1104486 A4 EP 1104486A4
Authority
EP
European Patent Office
Prior art keywords
staging
diagnosing
imaging
monitoring
lung cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99935685A
Other languages
English (en)
French (fr)
Other versions
EP1104486A1 (de
Inventor
Fei Yang
Yongming Sun
Herve Recipon
Roberto A Macina
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diadexus Inc
Original Assignee
Diadexus Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diadexus Inc filed Critical Diadexus Inc
Publication of EP1104486A1 publication Critical patent/EP1104486A1/de
Publication of EP1104486A4 publication Critical patent/EP1104486A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A61K49/16—Antibodies; Immunoglobulins; Fragments thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Analytical Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Optics & Photonics (AREA)
  • Toxicology (AREA)
  • Radiology & Medical Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP99935685A 1998-08-04 1999-07-19 Neues verfahren zur diagnose, zur verlaufsbeobachtung und zum abbilden von lungenkrebs Withdrawn EP1104486A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9523398P 1998-08-04 1998-08-04
US95233P 1998-08-04
PCT/US1999/016247 WO2000008206A1 (en) 1998-08-04 1999-07-19 A novel method of diagnosing, monitoring, staging, imaging and treating lung cancer

Publications (2)

Publication Number Publication Date
EP1104486A1 EP1104486A1 (de) 2001-06-06
EP1104486A4 true EP1104486A4 (de) 2002-07-17

Family

ID=22250833

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99935685A Withdrawn EP1104486A4 (de) 1998-08-04 1999-07-19 Neues verfahren zur diagnose, zur verlaufsbeobachtung und zum abbilden von lungenkrebs

Country Status (4)

Country Link
EP (1) EP1104486A4 (de)
JP (1) JP3524061B2 (de)
CA (1) CA2347656A1 (de)
WO (1) WO2000008206A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6869592B1 (en) 1998-08-04 2005-03-22 Diadexus, Inc. Method and antibody for imaging lung cancer
WO2002018576A2 (en) * 2000-08-28 2002-03-07 Diadexus, Inc. Compositions and methods relating to lung specific genes
AU2002241730A1 (en) * 2000-10-26 2002-06-18 Diadexus, Inc. Compositions and methods relating to lung specific genes and proteins
US20020160388A1 (en) * 2000-11-20 2002-10-31 Roberto Macina Compositions and methods relating to lung specific genes and proteins
EP1392829A2 (de) * 2000-11-20 2004-03-03 Diadexus, Inc. Zusammensetzungen und verfahren mit bezug zu lungen-spezifischen genen und proteinen
WO2002068633A2 (en) * 2000-11-22 2002-09-06 Diadexus, Inc. Compositions and methods relating to lung specific genes and proteins
DE10254601A1 (de) 2002-11-22 2004-06-03 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
DE102004024617A1 (de) 2004-05-18 2005-12-29 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
EP1790664A1 (de) 2005-11-24 2007-05-30 Ganymed Pharmaceuticals AG Monoklonale Antikörper gegen Claudin-18 zur Behandlung von Krebs
US7951781B2 (en) 2006-11-02 2011-05-31 University Of Iowa Research Foundation Methods and compositions related to PLUNC surfactant polypeptides
WO2013167153A1 (en) 2012-05-09 2013-11-14 Ganymed Pharmaceuticals Ag Antibodies useful in cancer diagnosis
KR102643443B1 (ko) 2012-11-13 2024-03-06 비온테크 에스이 클라우딘 발현 암 질환의 치료제

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0695760A1 (de) * 1994-08-05 1996-02-07 F. Hoffmann-La Roche Ag Tumormarker für Lungenkrebs
US5589579A (en) * 1994-07-19 1996-12-31 Cytoclonal Pharmaceutics, Inc. Gene sequence and probe for a marker of non-small cell lung carinoma
WO1998020143A1 (en) * 1996-11-05 1998-05-14 Abbott Laboratories Reagents and methods useful for detecting diseases of the lung
WO1998056951A1 (en) * 1997-06-11 1998-12-17 Abbott Laboratories Reagents and methods useful for detecting diseases of the lung
WO1999060160A1 (en) * 1998-05-21 1999-11-25 Diadexus Llc A novel method of diagnosing, monitoring, and staging lung cancer

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589579A (en) * 1994-07-19 1996-12-31 Cytoclonal Pharmaceutics, Inc. Gene sequence and probe for a marker of non-small cell lung carinoma
EP0695760A1 (de) * 1994-08-05 1996-02-07 F. Hoffmann-La Roche Ag Tumormarker für Lungenkrebs
WO1998020143A1 (en) * 1996-11-05 1998-05-14 Abbott Laboratories Reagents and methods useful for detecting diseases of the lung
WO1998056951A1 (en) * 1997-06-11 1998-12-17 Abbott Laboratories Reagents and methods useful for detecting diseases of the lung
WO1999060160A1 (en) * 1998-05-21 1999-11-25 Diadexus Llc A novel method of diagnosing, monitoring, and staging lung cancer

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO0008206A1 *

Also Published As

Publication number Publication date
WO2000008206A1 (en) 2000-02-17
EP1104486A1 (de) 2001-06-06
JP2002522046A (ja) 2002-07-23
CA2347656A1 (en) 2000-02-17
JP3524061B2 (ja) 2004-04-26

Similar Documents

Publication Publication Date Title
EP1105528A4 (de) Verfahren zur diagnose, überwachung, klassifizierung, bildgebungund behandlung von brustkrebs
EP1082459A4 (de) Neue methode zur diagnose, überwachung und bestimmung des stadiums von lungenkrebs
EP1239874A4 (de) Methode zur diagnose, überwachung, einstufung, bilddarstellung und behandlung von prostatakrebs
MXPA01008794A (es) Metodo para diagnosticar y verificar carcinomas de pecho malignos.
GB2345757B (en) Well logging apparatus and method
GB2286844B (en) Wellbore monitoring apparatus
GB2340152B (en) Multiple string completion apparatus and method
EP1123102A4 (de) Methoden zur verhinderung von akuten lungenverletzungen
EP0887424A4 (de) Diagnostische methode
ZA9811179B (en) Inhalation apparatus and method.
GB2344123B (en) Well logging method and apparatus
GB2303706B (en) Lung function monitoring apparatus flowheads
HU9900386D0 (en) Method for treating heart failure
EP1104486A4 (de) Neues verfahren zur diagnose, zur verlaufsbeobachtung und zum abbilden von lungenkrebs
EP1267934A4 (de) Neues verfahren zur diagnose, überwachung, statusbestimmung, bildmässiger darstellung und behandlung von brustkrebs
EP1107798A4 (de) Neues verfahren zur diagnose, überwachung, klassifizierung, bildgebung und behandlung von kolonkrebs
AU2001251223A1 (en) Compositions and methods for diagnosing, monitoring, staging, imaging and treating stomach cancer
GB9928480D0 (en) Apparatus and method for downhole telemetry
AU2001268633A1 (en) Method of diagnosing, monitoring, staging, imaging and treating breast cancer
GB9820919D0 (en) Diagnostic method
EP1082460A4 (de) Neuartiges verfahren zur diagnose, zur überwachung und verlaufsbeobachtung von prostatakrebs
AU2001241656A1 (en) Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes
EP1117833A4 (de) Ein neuartiges verfahren zur diagnose, feststellung, einstufung, darstellung sowie behandlung gastrointestinaler krebserkrankungen
AU2001271621A1 (en) Method of diagnosing, monitoring, staging, imaging and treating colon cancer
EP1126877A4 (de) Methode zur diagnose, überwachung, feststellung der krankheitsstufe, darstellung und behandlung von prostatakrebs

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010305

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20020604

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7G 01N 33/574 A, 7C 07K 16/30 B, 7C 12Q 1/68 B, 7A 61K 39/395 B

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: DIADEXUS, INC.

17Q First examination report despatched

Effective date: 20030630

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050924